Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

Bayer Crop Sciences is focusing on rebuilding trust in its main business areas, like seeds and crop protection, and showing a ...

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

Bayer (XTRA:BAYN) has quietly staged a strong rebound over the past month, with shares up around 14% and roughly 34% in the ...

BAYRY shares have risen 121.6% in a year as new FDA approvals, pipeline wins and litigation updates fuel a sharp turnaround.

Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The timing of Bayer's lawsuit ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...

Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug which had previously showed to be ineffective in another trial. The ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

The Food and Drug Administration (FDA) on Wednesday granted accelerated approval to Bayer AG‘s (OTC: BAYRY) Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. The approval ...

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.